nach oben

Erschienen in:

12.01.2024 | Intensivmedizin

Natriuretische Peptide in der Intensivmedizin

verfasst von: Dr. Stefan Großmann, Dr. Florian Geisreiter, Dr. Stephan Schroll

Erschienen in: Wiener klinisches Magazin | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Zusammenfassung

Natriuretische Peptide müssen gerade in der Intensivmedizin in ihrem klinischen Kontext interpretiert werden. In dieser Übersicht wird die diagnostische, prognostische und therapeutische Bedeutung von BNP und NT-proBNP bei Patienten mit kardialer Dysfunktion, Nierenversagen, Sepsis, Lungenembolie, ARDS, AECOPD und im Weaning vom Respirator dargestellt.

Vorheriger Artikel Das Second-Victim-Phänomen

Nächster Artikel CO2-Fußabdruck der Intensivmedizin – „let’s go green“

Ammari Z, Al-Sarie M, Ea A et al (2021) Predictors of reduced cardiac index in patients with acute submassive pulmonary embolism. Catheter Cardiovasc Interv 97:292–298PubMedCrossRef

Anwaruddin S, Lloyd-Jones DM, Baggish A et al (2006) Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP investigation of dyspnea in the emergency department (PRIDE) study. J Am Coll Cardiol 47:91–97PubMedCrossRef

Booth J, Pinney J, Davenport A (2010) N‑terminal proBNP—marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients? Clin J Am Soc Nephrol 5:1036–1040PubMedPubMedCentralCrossRef

Cavallazzi R, Nair A, Vasu T et al (2008) Natriuretic peptides in acute pulmonary embolism: a systematic review. Intensive Care Med 34:2147–2156PubMedCrossRef

de Cal M, Haapio M, Cruz DN et al (2011) B‑type natriuretic peptide in the critically ill with acute kidney injury. Int J Nephrol 2011:951629PubMedPubMedCentral

Deschamps J, Andersen SK, Webber J et al (2020) Brain natriuretic peptide to predict successful liberation from mechanical ventilation in critically ill patients: a systematic review and meta-analysis. Crit Care 24:213PubMedPubMedCentralCrossRef

Ediboğlu Ö, Kıraklı C (2018) Can NT-pro BNP levels predict prognosis of patients with acute exacerbations of chronic obstructive pulmonary disease in the intensive care unit? Balkan Med J 35:422–426PubMedPubMedCentral

Feiz Disfani H, Lari S, Attaran D et al (2016) The early effectiveness of noninvasive positive pressure ventilation on right ventricular function in chronic obstructive pulmonary disease patients with acute hypercapnic respiratory failure. B23. Cardiovascular and respiratory interactions IN COPD. American Thoracic Society, S A2986

Hall C (2004) Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 6:257–260PubMedCrossRef

10.

Hartemink KJ, Twisk JW, Groeneveld AB (2011) High circulating N‑terminal pro-B-type natriuretic peptide is associated with greater systolic cardiac dysfunction and nonresponsiveness to fluids in septic vs nonseptic critically ill patients. J Crit Care 26:108.e1–108.e8PubMedCrossRef

11.

Ikonomidis I, Nikolaou M, Dimopoulou I et al (2010) Association of left ventricular diastolic dysfunction with elevated Nt-pro-BNP in general intensive care unit patients with preserved ejection fraction: a complementary role of tissue doppler imaging parameters and Nt-pro-BNP Levels for adverse outcome. Shock 33:141–148PubMedCrossRef

12.

Janssens U, Joannidis M (2016) Acute cardiorenal syndromes. Med Klin Intensivmed Notfmed 111:341–358PubMedCrossRef

13.

Jayasimhan D, Foster S, Chang CL et al (2021) Cardiac biomarkers in acute respiratory distress syndrome: a systematic review and meta-analysis. j intensive care 9:36PubMedPubMedCentralCrossRef

14.

Karmpaliotis D, Kirtane AJ, Ruisi CP et al (2007) Diagnostic and prognostic utility of brain natriuretic peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema. Chest 131:964–971PubMedCrossRef

15.

Kharasch ED, Yeo KT, Kenny MA et al (1988) Atrial natriuretic factor may mediate the renal effects of PEEP ventilation. Anesthesiology 69:862–869PubMedCrossRef

16.

Klouche K, Pommet S, Amigues L et al (2014) Plasma brain natriuretic peptide and troponin levels in severe sepsis and septic shock: relationships with systolic myocardial dysfunction and intensive care unit mortality. J Intensive Care Med 29:229–237PubMedCrossRef

17.

Komiya K, Akaba T, Kozaki Y et al (2017) A systematic review of diagnostic methods to differentiate acute lung injury/acute respiratory distress syndrome from cardiogenic pulmonary edema. Crit Care 21:228PubMedPubMedCentralCrossRef

18.

Konstantinides SV, Meyer G, Becattini C et al (2020) 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS). Eur Heart J 41:543–603PubMedCrossRef

19.

Liu J, Wang CJ, Ran JH et al (2021) The predictive value of brain natriuretic peptide or N‑terminal pro-brain natriuretic peptide for weaning outcome in mechanical ventilation patients: evidence from SROC. J Renin Angiotensin Aldosterone Syst 22:1470320321999497PubMedPubMedCentralCrossRef

20.

Luchner A, Weidemann A, Willenbrock R et al (2010) Improvement of the cardiac marker N‑terminal-pro brain natriuretic peptide through adjustment for renal function: a stratified multicenter trial. Clin Chem Lab Med 48:121–128PubMedCrossRef

21.

Madamanchi C, Alhosaini H, Sumida A et al (2014) Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure. Int J Cardiol 176:611–617PubMedPubMedCentralCrossRef

22.

Maeder M, Fehr T, Rickli H et al (2006) Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 129:1349–1366PubMedCrossRef

23.

Mclean AS, Tang B, Nalos M et al (2003) Increased B‑type natriuretic peptide (BNP) level is a strong predictor for cardiac dysfunction in intensive care unit patients. Anaesth Intensive Care 31:21–27PubMedCrossRef

24.

Mekontso Dessap A, Roche-Campo F, Kouatchet A et al (2012) Natriuretic peptide-driven fluid management during ventilator weaning: a randomized controlled trial. Am J Respir Crit Care Med 186:1256–1263PubMedCrossRef

25.

Mekontso-Dessap A, de Prost N, Girou E et al (2006) B‑type natriuretic peptide and weaning from mechanical ventilation. Intensive Care Med 32:1529–1536PubMedCrossRef

26.

Mueller C, Mcdonald K, de Boer RA et al (2019) Heart failure association of the European society of cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail 21:715–731PubMedCrossRef

27.

Noveanu M, Pargger H, Breidthardt T et al (2011) Use of B‑type natriuretic peptide in the management of hypoxaemic respiratory failure. Eur J Heart Fail 13:154–162PubMedCrossRef

28.

Ouellette DR, Patel S, Girard TD et al (2017) Liberation from mechanical ventilation in critically ill adults: an official American college of chest physicians/American thoracic society clinical practice guideline: inspiratory pressure augmentation during spontaneous breathing trials, protocols minimizing sedation, and noninvasive ventilation immediately after extubation. Chest 151:166–180PubMedCrossRef

29.

Papanikolaou J, Makris D, Mpaka M et al (2014) New insights into the mechanisms involved in B‑type natriuretic peptide elevation and its prognostic value in septic patients. Crit Care 18:R94PubMedPubMedCentralCrossRef

30.

Park S, Cho GY, Kim SG et al (2009) Brain natriuretic peptide levels have diagnostic and prognostic capability for cardio-renal syndrome type 4 in intensive care unit patients. Crit Care 13:R70PubMedPubMedCentralCrossRef

31.

Pirracchio R, Deye N, Lukaszewicz AC et al (2008) Impaired plasma B‑type natriuretic peptide clearance in human septic shock. Crit Care Med 36:2542–2546PubMedCrossRef

32.

Post F, Weilemann LS, Messow CM et al (2008) B‑type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients. Crit Care Med 36:3030–3037PubMedCrossRef

33.

Ricci Z, Garisto C, Morelli S et al (2009) Brain natriuretic peptide is removed by continuous veno-venous hemofiltration in pediatric patients. Interact CardioVasc Thorac Surg 9:33–36PubMedCrossRef

34.

Sawatani T, Shirakabe A, Okazaki H et al (2021) Clinical significance of the N‑terminal pro-brain natriuretic peptide and B‑type natriuretic peptide ratio in the acute phase of acute heart failure. Eur Heart J Acute Cardiovasc Care 10:1016–1026PubMedCrossRef

35.

Sevilla Berrios RA, O’horo JC, Velagapudi V et al (2014) Correlation of left ventricular systolic dysfunction determined by low ejection fraction and 30-day mortality in patients with severe sepsis and septic shock: a systematic review and meta-analysis. J Crit Care 29:495–499PubMedCrossRef

36.

Shor R, Rozenman Y, Bolshinsky A et al (2006) BNP in septic patients without systolic myocardial dysfunction. Eur J Intern Med 17:536–540PubMedCrossRef

37.

Short PM, Anderson WJ, Elder DH et al (2015) Impact of left ventricular hypertrophy on survival in chronic obstructive pulmonary disease. Am J Physiol 193:487–495

38.

Singh H, Ramai D, Patel H et al (2017) B‑type natriuretic peptide: a predictor for mortality, intensive care unit length of stay, and hospital length of stay in patients with resolving sepsis. Cardiol Res 8:271–275PubMedPubMedCentralCrossRef

39.

Stolz D, Breidthardt T, Christ-Crain M et al (2008) Use of B‑type natriuretic peptide in the risk stratification of acute exacerbations of COPD. Chest 133:1088–1094PubMedCrossRef

40.

Sturgess DJ, Pascoe RL, Scalia G et al (2010) A comparison of transcutaneous Doppler corrected flow time, b‑type natriuretic peptide and central venous pressure as predictors of fluid responsiveness in septic shock: a preliminary evaluation. Anaesth Intensive Care 38:336–341PubMedCrossRef

41.

Tanabe Y, Obayashi T, Yamamoto T et al (2015) Predictive value of biomarkers for the prognosis of acute pulmonary embolism in Japanese patients: results of the Tokyo CCU network registry. J Cardiol 66:460–465PubMedCrossRef

42.

Tulevski I, ten Wolde M, van Veldhuisen DJ et al (2007) Combined utility of brain natriuretic peptide and cardiac troponin T may improve rapid triage and risk stratification in normotensive patients with pulmonary embolism. Int J Cardiol 116:161–166PubMedCrossRef

43.

Vallabhajosyula S, Haddad TM, Sundaragiri PR et al (2018) Role of B‑type natriuretic peptide in predicting in-hospital outcomes in acute exacerbation of chronic obstructive pulmonary disease with preserved left ventricular function: a 5‑year retrospective analysis. J Intensive Care Med 33:635–644PubMedCrossRef

44.

Vallabhajosyula S, Wang Z, Murad MH et al (2020) Natriuretic peptides to predict short-term mortality in patients with sepsis: a systematic review and meta-analysis. Mayo Clin Proc Innov Qual Outcomes 4:50–64PubMedPubMedCentralCrossRef

45.

Wu ZH, Tang Y, Zhao M et al (2021) Association between elevated brain natriuretic peptide levels and weaning failure: a systematic review and meta-analysis. Int J Clin Pract 75:e14850PubMedCrossRef

Titel: Natriuretische Peptide in der Intensivmedizin
verfasst von: Dr. Stefan Großmann
Dr. Florian Geisreiter
Dr. Stephan Schroll
Publikationsdatum: 12.01.2024
Verlag: Springer Vienna
Erschienen in: Wiener klinisches Magazin / Ausgabe 1/2024
Print ISSN: 1869-1757
Elektronische ISSN: 1613-7817
DOI: https://doi.org/10.1007/s00740-023-00517-9

CO2-Fußabdruck der Intensivmedizin – „let’s go green“

Intensivmedizin & Umwelt

Das Second-Victim-Phänomen

Praxis und Beruf
Anästhesie

Panorama

Panorama

Ambulant erworbene Pneumonie

Lungenerkrankungen
Pulmologie

Weit verbreitet – wenig bekannt

Editorial

Springer Medizin Österreich

Natriuretische Peptide in der Intensivmedizin

Zusammenfassung

Weitere Artikel der Ausgabe 1/2024

CO2-Fußabdruck der Intensivmedizin – „let’s go green“

Das Second-Victim-Phänomen

Panorama

Ambulant erworbene Pneumonie

Weit verbreitet – wenig bekannt

Springer Medizin Österreich

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

CO2-Fußabdruck der Intensivmedizin – „let’s go green“

Das Second-Victim-Phänomen

Panorama

Ambulant erworbene Pneumonie

Weit verbreitet – wenig bekannt